货号 | AF757-SP |
别名 | BMP-2B; BMP2B1; BMP2BMCOPS6; BMP-4; Bone morphogenetic protein 2B; bone morphogenetic protein 4; DVR4; OFC11; ZYME | 全称 | Bone Morphogenetic Protein 4 |
反应种属 | Human |
应用 | Western Blot(0.1 µg/mL) |
目标/特异性 | Detects human BMP-4 in direct ELISAs and Western blots. In direct ELISAs, approximately 35% cross-reactivity with recombinant human (rh) BMP‑2 and 10% cross-reactivity with rhBMP-5 and rhBMP-6 is observed. |
使用方法 | Western Blot: 0.1 µg/mL Neutralization: Measured by its ability to neutralize BMP‑4-induced alkaline phosphatase production in the ATDC5 mouse chondrogenic cell line [Nakamura, K. et al. (1999) Exp. Cell Res. 250:351]. The Neutralization Dose (ND50) is typically 0.5-2.0 µg/mL in the presence of 15 ng/mL Recombinant Human BMP‑4 and 2 µg/mL heparin. |
来源 | Polyclonal Goat IgG |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 652 (Human); 12159 (Mouse); 25296 (Rat); 30612 (Zebrafish) |
应用文献 | |
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Malignant transformation of multipotent muscle-derived cells by concurrent differentiation signals. | |
纯化方式 | Antigen Affinity-purified |
免疫原 | Mouse myeloma cell line NS0-derived recombinant human BMP‑4 Ser293-Arg408 Accession # P12644 |
内毒素水平 | <0.30 EU per 1 μg of the antibody by the LAL method. |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitute at 0.2 mg/mL in sterile PBS. |
背景 | BMP-4 is a TGF-beta superfamily ligand that is widely expressed from early embryogenesis through adulthood. It plays an important role in mesenchyme formation, epidermal determination, suppression of neural induction, the development of multiple organs, and tissue repair (1 - 5). The human BMP-4 precursor contains a 273 amino acid (aa) propeptide and a 116 aa mature protein (6). Processing of the propeptide by furin or proprotein convertase 6 enables the formation of the mature disulfide-linked homodimeric BMP-4 and facilitates its secretion. Similar intracellular processes may lead to the formation and recreation of BMP4/BMP7 disulfide-linked heterodimer (7 - 9). Mature human and mouse BMP-4 share 98% aa sequence identity. Human BMP-4 shares 85% aa sequence identity with human BMP-2 and less than 50% with other human BMPs. Compared to BMP-4 homodimers, BMP-4/BMP-7 heterodimers exhibit a greater potency in inducing osteogenic differentiation (9). In Xenopus, the heterodimers can also induce the formation of mesoderm, whereas BMP-4 homodimers only provide ventralizing signals for existing mesoderm (10). BMP-4 signals through tetrameric complexes composed of type I (primarily Activin RIA or BMPR‑IA) and type II (primarily Activin RIIA or BMPR-II) receptors (11, 12). The bioavailability of BMP-4 is regulated by its interaction with multiple proteins and glycosaminoglycans (13 - 15).
|
运输条件 | Blue Ice |
存放说明 | 4℃ |
参考文献 |
|
Alkaline Phosphatase Production Induced by BMP‑4 and Neutralization by Human BMP‑4 Antibody. Recombinant Human BMP‑4 (Catalog # 314-BP) induces alkaline phosphatase production in the the ATDC5 mouse chondrogenic cell line in a dose-dependent manner (orange line). Alkaline phosphatase production elicited by Recombinant Human BMP‑4 (15 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human BMP‑4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF757). The ND50 is typically 0.5-2.0 µg/mL in the presence of heparin (2 µg/mL). |